On-site sol-gel-sol transition of alginate enables reversible shielding/deshielding of tumor cell-activated nanoconjugates for precise local colorectal cancer therapy

Although local colorectal cancer (CRC) therapy can be achieved by delivering CRC-targeted nanoparticles directly to the tumor tissues within the colorectal cavity, bypassing systemic circulation thr